Meera Shreedhara Vasudha in Dallas, Texas

Home Texas Dallas

Meera Shreedhara Vasudha has Medical Oncology as her primary medical specialty. Their primary office is: 10425 N Central Expy in Dallas, Texas. There is an additional office location, for a total of two, for Meera Shreedhara Vasudha that can be viewed further down.

They're a part of the: Texas Oncology Pa medical group which has around 833 members. You can call their office at 214-361-2025 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2000 (around 24 years of experience). They are listed as doing telehealth appointments.

Meera Shreedhara Vasudha Office Phone and Directions

Meera Shreedhara Vasudha
Texas Oncology Pa
10425 N Central Expy
Dallas, Texas 75231
214-361-2025

Patient Ratings
Please rate your experience with Meera Shreedhara Vasudha below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 214-361-2025

Enter a starting address:

Healthcare Info for Meera Shreedhara Vasudha

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 2000
The Primary Medical Specialty for Meera Shreedhara Vasudha is listed as: Medical Oncology
Approximate Years of Experience: 24
PAC (PECOS ID)#: 9931298841
NPI #: 1639388689
NPI Created On: 05/22/2007
NPI Last Updated Listed as: 03/09/2021
Primary Taxonomy Code: 207RH0003X
License Number:
M5507
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

FirstCare Health Plans
Molina Marketplace
Celtic Insurance Company
CHRISTUS Health Plan
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

Declotting infusion of implanted central venous access device or catheter
Bone marrow biopsy and aspiration
Vaccine for influenza for administration into muscle, 0.5 ml dosage
Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage
Hydration infusion into a vein 31 minutes to 1 hour
Hydration infusion into a vein
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of drug or substance into a vein for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
Infusion of different chemotherapy drug or substance into a vein
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813262035

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813262039

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813262043

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813262047

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813262051

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813262055

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Payments Total: $31

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;KP31492;KPConcur;11037358

Record ID:: 844421795

Being Disputed:: No

Product Related: Yes

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2780907;EPRINTS;11037358

Record ID:: 845879271

Being Disputed:: No

Product Related: Yes

Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 835534907

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hematology/Oncology

Name of Drug #1: JAKAFI

Open Associated Drug #1: 50881-005-60

Drug or Biological: Drug

Product Category #2: Hepatology (Liver, Pancreatic, Gall Bladder)

Name Of Drug #2:: PEMAZYRE

Associated Drug #2: 50881-026-01

Additional Office Locations

1. Texas Oncology Pa
4215 Joe Ramsey Blvd
Greenville, TX 75401
Group Members: 833

Phone: 214-361-2025

Enter a starting address:

Medical Oncology Professionals in Dallas

1.
Roy Paulson MD

3410 Worth St
Dallas, TX
Texas Oncology Pa

2.
Barry Brooks

7777 Forest Ln
Dallas, TX
Texas Oncology Pa

3.
Barry Brooks

10425 N Central Expy
Dallas, TX
Texas Oncology Pa

4.
Barry Brooks

3410 Worth St
Dallas, TX
Texas Oncology Pa

5.
Poorni Manohar

2201 Inwood Rd
Dallas, TX
University Of Texas Southwestern Medical Center

6.
Poorni Manohar

5200 Harry Hines Blvd
Dallas, TX
University Of Texas Southwestern Medical Center

Providers in Texas Oncology Pa

1.Mirna Abboud

501 W Medical Ctr Blvd
Webster Tx 77598-4219
Texas Oncology Pa
Radiation Oncology

2.Seyed Abedi

501 W Medical Ctr Blvd
Webster Tx 77598-4219
Texas Oncology Pa
Hematology/oncology

3.Seyed Abedi

1401 Medical Pkwy
Cedar Park Tx 78613-5026
Texas Oncology Pa
Hematology/oncology

4.Laith Abushahin

3705 W 15th St
Plano Tx 75075-7753
Texas Oncology Pa
Medical Oncology

5.Laith Abushahin

3410 Worth St
Dallas Tx 75246-2092
Texas Oncology Pa
Medical Oncology

6.Maria Acevedo

7848 Gateway Blvd E
El Paso Tx 79915-1815
Texas Oncology Pa
Nurse Practitioner

View all 833 members of Texas Oncology Pa medical group